参考文献/References:
[1] Nkomo VT,Gardin JM,Skelton TN,et al.Burden of valvular heart diseases:a population-based study[J].Lancet,2006,368:1005-1011.
[2]Mirabel M,Iung B,Baron G,et al.What are the characteristics of patients with severe,symptomatic,mitral regurgitation who are denied surgery?[J].Eur Heart J,2007,28:1358-1365.
[3]Goel SS,Bajaj N,Aggarwal B,et al.Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure:comprehensive analysis to determine the potential role of MitraClip for this unmet need[J].J Am Coll Cardiol,2014,63:185-186.
[4]Walther C,Fichtlscherer S,Holubec T,et al.New developments in transcatheter therapy of mitral valve disease[J].J Thorac Dis,2020,12:1728-1739.
[5]Vahanian A,Beyersdorf F,Praz F,et al.2021 ESC/EACTS Guidelines for the management of valvular heart disease[J].Eur Heart J,2022,43:561-632.
[6]Vonbardeleben R S,Mahoney P,Morse M A,et al.1-Year outcomes with fourth-generation mitral valve transcatheter edge-to-edge repair from the EXPAND G4 Study[J].JACC Cardiovasc Interv,2023,16:2600-2610.
[7]赵玉玺,鲍贤豪,曾照祥,等.经导管二尖瓣置换术治疗二尖瓣反流研究进展[J].介入放射学杂志,2019,28:1000-1004.
Zhao YX,Bao XH,Zeng ZX,et al.Research progress in transcatheter mitral valve replacement for Mitral regurgitation[J].J Intervent Radiol,2019,28:1000-1004.
[8]Zahr F,Song H K,Chadderdon S,et al.1-Year outcomes following transfemoral transseptal transcatheter mitral valve replacement:Intrepid TMVR early feasibility study results[J].JACC Cardiovasc Interv,2023,16:2868-2879.
[9]Conradi L,Ludwig S,Sorajja P,et al.Clinical outcomes and predictors of transapical transcatheter mitral valve replacement:the tendyne expanded clinical study[J].Euro Intervention,2024,20:e887-e897.
[10]DelVal D,Ferreira-Neto AN,Wintzer-Wehekind J,et al.Early experience with transcatheter mitral valve replacement:a systematic review[J].J Am Heart Assoc,2019,8:e013332.
[11]Guerrero M,Dvir D,Himbert D,et al.Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification:results from the first multicenter global registry[J].JACC Cardiovasc Interv,2016,9:1361-1371.
[12]Genereux P,Wrobel K,Ninios V,et al.6-Month Outcomes of a Supra-Annular Transcatheter Mitral Valve Replacement:An Early Feasibility Study[J].JACC Cardiovasc Interv,2025,18:2584-2592.
(收稿日期:2025-04-21)
(本文编辑:新 宇)
相似文献/References:
[1]朱文科 单鸿 朱康顺 姜在波 李征然 黄明声 关守海 沈新颖.经颈静脉肝内门体分流术治疗顽固性腹水[J].介入放射学杂志,2004,(01):11.
[2]王仲朴,王茂强,吴朝阳.经导管子宫动脉栓塞治疗症状性子宫平滑肌瘤的初步经验[J].介入放射学杂志,2000,(04):210.
[3]王仲朴 王茂强 孙永光 刘晓君.含钆造影剂在动脉血管造影和介入治疗中的初步应用[J].介入放射学杂志,2002,(02):97.
[4]陆骊工,胡宝山,李勇,等.中晚期原发性肝癌合并症的介入治疗研究[J].介入放射学杂志,2008,(07):514.
LU Ligong,HU Baoshan,LI Yong,et al.Study of interventional therapy for complications in advanced primary hepatocellular carcinoma[J].J Intervent Med,2008,(03):514.
[5]白卫星,姜喜锋,李天晓,等.Neuroform自膨式支架结合弹簧圈栓塞颅内宽颈动脉瘤[J].介入放射学杂志,2008,(08):539.
BAI Weixing,JIANG Xifeng,LI Tianxiao,et al.Treatment of intracranial wide neck aneurysm with neuroform self-expanding stent combined with spring coils[J].J Intervent Med,2008,(03):539.
[6]李天晓,白卫星,翟水亭,等.颅底动脉损伤的介入治疗[J].介入放射学杂志,2008,(08):535.
LI Tianxiao,BAI Weixing,ZAI Suiting,et al.Endovascular treatment for arterial injuries of skull base[J].J Intervent Med,2008,(03):535.
[7]佟小强,杨敏,王健,等.超选择动脉栓塞术治疗动脉性消化道出血[J].介入放射学杂志,2008,(10):732.
TONG Xiaoqiang,YANG Min,WANG Jian,et al.Superselective intraarterial embolization in treating gastrointestinal hemorrhage[J].J Intervent Med,2008,(03):732.
[8]吕益忠,陈亚梅.宫颈腺癌及其血管内介入治疗[J].介入放射学杂志,2008,(10):750.
LüYizhong,CHEN Yamei.Intravascular interventional therapy for uterine cervical adenocarcinoma[J].J Intervent Med,2008,(03):750.
[9]赵林,李林芳,刘增品,等.改良溶栓方案治疗解剖变异的脑静脉窦血栓形成[J].介入放射学杂志,2010,(03):174.
ZHAO Lin,LI Linfang,LIU Zengpin,et al.A modified thrombolytic scheme for the treatment of thrombosis in anatomically varied cerebral venous sinus[J].J Intervent Med,2010,(03):174.
[10]张晓军,张新荣,唐文伟,等.心血管造影及超声检查在小儿先天性心脏病介入治疗中的联合应用研究[J].介入放射学杂志,2010,(03):177.
ZHANG Xiaojun,ZHANG Xinrong,TANG Wenwei,et al.The combined use of cardioangiography and ultrasonography in interventional therapy for congenital heart disease in children[J].J Intervent Med,2010,(03):177.